🇺🇸 FDA

Drug profile · INN

bupivacaine

EXPAREL LIPOSOMAL

approved N01BB01
US status
approved
Patents linked
8
News articles
0

Quick answer

bupivacaine (EXPAREL LIPOSOMAL) is an FDA-listed pharmaceutical active ingredient. Associated with Pacira Ireland Limited. Route of administration: periarticular. Current US regulatory status: approved.

Key facts

INN bupivacaine
Brand EXPAREL LIPOSOMAL
Route PERIARTICULAR
Formulation INJECTABLE, LIPOSOMAL
ATC code N01BB01
Originator Pacira Ireland Limited

Related patents

Search patents →

  1. US 12370142

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Jul 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12318483

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12296047

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12285419

    Bupivacaine multivesicular liposome formulations and uses thereof

    Expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12280149

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12251468

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12246092

    Manufacturing of bupivacaine multivesicular liposomes

    Expires Mon Mar 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is bupivacaine?

bupivacaine (EXPAREL LIPOSOMAL) is an FDA-listed pharmaceutical active ingredient. Associated with Pacira Ireland Limited. Route of administration: periarticular. Current US regulatory status: approved.

What is the brand name for bupivacaine?

EXPAREL LIPOSOMAL is a marketed brand name for bupivacaine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bupivacaine?

bupivacaine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.